… influence real-world performance of … dabigatran use are important to validate results from
the RE-LY trial. Overall, the available real-world data on the efficacy and safety of dabigatran in …

… persistence rates of 11,350 dabigatran users were 24.5… dabigatran is a relatively new drug
in China. Compared with other reported data, patients of this study have (1) lower dabigatran …

… the safety and efficacy of dabigatran relative to warfarin for stroke prevention in non-valvular
atrial fibrillation. It is important to further evaluate safety … to compare dabigatran with warfarin …

… We also recorded indications for dabigatran use, the daily dabigatran dosage, and laboratory
data both before and after idarucizumab infusion, including creatinine clearance, activated …

… The efficacy and safety of dabigatran for the prevention of stroke and systemic embolism in
… 110 mg dabigatran twice daily (bid), 150 mg dabigatran bid (the two dabigatran doses were …

… However, a head‐to‐head comparison between dabigatran and rivaroxaban has never …
real‐world data concerning the comparative effectiveness and clinical safety of dabigatran and …

… Our data highlight that across a broad patient population, the real-world safety and effectiveness
of dabigatran compared to VKAs do not differ from those of the randomized clinical trial …

… of dabigatran has brought much anticipation and excitement, numerous challenges have
also been raised regarding its safe … to implementing safe and effective use of dabigatran and …

… Recent observational studies suggest that the risk of bleeding with dabigatran may be lower
… dabigatran literature pertaining to the geriatric population, identify risk factors for dabigatran-…

… We report the real-world rate of major bleeding observed in patients receiving either dabigatran
or rivaroxaban for the indication of AF over 2 years upon retrospective review. Our study …